Literature DB >> 8998127

Glutamine extraction by the gut is reduced in depleted [corrected] patients with gastrointestinal cancer.

R R van der Hulst1, M F von Meyenfeldt, N E Deutz, P B Soeters.   

Abstract

OBJECTIVE AND SUMMARY BACKGROUND DATA: Glutamine is an important fuel for the intestinal mucosa. However, glutamine pools may become depleted in the cancer-bearing host as a result of tumor consumption and diminished production due to nutritional depletion. As human data are lacking, the authors investigated glutamine extraction by different sites of the human intestine, including tumor and the potential relation with the degree of nutritional depletion.
METHODS: Thirty-two patients with gastrointestinal malignancies were studied. Blood from an artery and veins draining jejunum, ileum, colon, or tumor were sampled. Depletion was estimated by the percentage ideal body weight.
RESULTS: Fractional glutamine extraction rate in the jejunum was 24%, three times higher than in ileum and colon. Percentage ideal body weight correlated with arterial glutamine levels (r = 0.5275, p = 0.003). In addition, arterial glutamine concentrations were correlated with extraction in the ileum (r = -0.8411, p < 0.001). Colon-containing tumor did not extract more glutamine than did nontumor-containing colon.
CONCLUSIONS: Glutamine is a quantitatively more important substrate for the proximal intestine than for the distal gut. Nutritional depletion results in decreased arterial glutamine concentration, which in turn results in diminished extraction. Colon cancer does not function as a glutamine trap and does not contribute to glutamine depletion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8998127      PMCID: PMC1190613          DOI: 10.1097/00000658-199701000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  37 in total

Review 1.  Gut glutamine metabolism.

Authors:  W W Souba; K Herskowitz; R M Salloum; M K Chen; T R Austgen
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Jul-Aug       Impact factor: 4.016

2.  Splanchnic, renal, and muscle clearance of alanylglutamine in man and organ fluxes of alanine and glutamine when infused in free and peptide forms.

Authors:  H Lochs; E Roth; S Gasic; W Hübl; E L Morse; S A Adibi
Journal:  Metabolism       Date:  1990-08       Impact factor: 8.694

3.  Uptake and metabolism of plasma glutamine by the small intestine.

Authors:  H G Windmueller; A E Spaeth
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

4.  Weight loss with physiologic impairment. A basic indicator of surgical risk.

Authors:  J A Windsor; G L Hill
Journal:  Ann Surg       Date:  1988-03       Impact factor: 12.969

5.  Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column.

Authors:  H M van Eijk; D R Rooyakkers; N E Deutz
Journal:  J Chromatogr       Date:  1993-10-22

6.  Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.

Authors:  T R Ziegler; L S Young; K Benfell; M Scheltinga; K Hortos; R Bye; F D Morrow; D O Jacobs; R J Smith; J H Antin
Journal:  Ann Intern Med       Date:  1992-05-15       Impact factor: 25.391

7.  Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery.

Authors:  P Stehle; J Zander; N Mertes; S Albers; C Puchstein; P Lawin; P Fürst
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

8.  Post-operative changes in hepatic, intestinal, splenic and muscle fluxes of amino acids and ammonia in pigs.

Authors:  N E Deutz; P L Reijven; G Athanasas; P B Soeters
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

9.  The dipeptide alanyl-glutamine prevents intestinal mucosal atrophy in parenterally fed rats.

Authors:  H Tamada; R Nezu; I Imamura; Y Matsuo; Y Takagi; S Kamata; A Okada
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Mar-Apr       Impact factor: 4.016

10.  Altered glutamine metabolism in rat portal drained viscera and hindquarter during hyperammonemia.

Authors:  C H Dejong; M T Kampman; N E Deutz; P B Soeters
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

View more
  12 in total

1.  Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.

Authors:  M Plauth; A E Roske; P Romaniuk; E Roth; R Ziebig; H Lochs
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

Review 2.  A serendipitous voyage in the field of nutrition and metabolism in health and disease: a translational adventure.

Authors:  Peter B Soeters
Journal:  Eur J Clin Nutr       Date:  2020-02-14       Impact factor: 4.016

3.  Both high and low plasma glutamine levels predict mortality in critically ill patients.

Authors:  Takae Tsujimoto; Kentaro Shimizu; Nobuaki Hata; Tatsuya Takagi; Etsuko Uejima; Hiroshi Ogura; Masafumi Wasa; Takeshi Shimazu
Journal:  Surg Today       Date:  2017-04-03       Impact factor: 2.549

Review 4.  Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.

Authors:  Ludy Lutgens; Philippe Lambin
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

5.  Intestinal and hepatic metabolism of glutamine and citrulline in humans.

Authors:  Marcel C G van de Poll; Gerdien C Ligthart-Melis; Petra G Boelens; Nicolaas E P Deutz; Paul A M van Leeuwen; Cornelis H C Dejong
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

6.  Glutamine: A novel approach to chemotherapy-induced toxicity.

Authors:  Kumar Gaurav; R K Goel; Mridula Shukla; Manoj Pandey
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01

Review 7.  A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2018-05-24

8.  Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?

Authors:  Bernd Sido; Cornelia Seel; Achim Hochlehnert; Raoul Breitkreutz; Wulf Dröge
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

9.  Long-term differential changes in mouse intestinal metabolomics after γ and heavy ion radiation exposure.

Authors:  Amrita K Cheema; Shubhankar Suman; Prabhjit Kaur; Rajbir Singh; Albert J Fornace; Kamal Datta
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Enteral Glutamine Administration in Critically Ill Nonseptic Patients Does Not Trigger Arginine Synthesis.

Authors:  Mechteld A R Vermeulen; Saskia J H Brinkmann; Nikki Buijs; Albertus Beishuizen; Pierre M Bet; Alexander P J Houdijk; Johannes B van Goudoever; Paul A M van Leeuwen
Journal:  J Nutr Metab       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.